Stocks
Relay Therapeutics, Inc.RLAY
NASDAQHealthcareBiotechnology$10.36-1.80%
Develops targeted cancer therapies using a structure‑based drug discovery platform that integrates computational modeling with experimental biology. Its pipeline focuses on precision oncology and genetic diseases, with lead programs aimed at inhibiting specific protein mutations such as FGFR2. Inves...
Market Cap: $1.9B52W Range: $1.77 – $11.49
Congressional Interest in Relay Therapeutics, Inc. (RLAY)
1 member of Congress has disclosed 1 trade in Relay Therapeutics, Inc. (RLAY), a Healthcare company. The buy/sell breakdown shows 0 purchases versus 1 sale, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
1
Unique Politicians
1
Buys
0
Sells
1
Who in Congress Is Trading RLAY?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2023-07-12 | Daniel Goldman | sell | $1K – $15K |